January 30, 2013

Aetna is offering individual health insurance plans to Costco members in California, the health insurer said.

January 30, 2013

A patch for treating menopause that the manufacturer calls the smallest is now available.

January 29, 2013

Eli Lilly and Company reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

January 29, 2013

The battle against biogenerics is on, noted a report published in The New York Times.

January 29, 2013

Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

January 28, 2013

U.S. generic drug maker Amneal Pharmaceuticals has entered a deal with South Korean drug maker Hanmi Pharmaceutical to acquire exclusive distribution rights for a Hanmi drug used for treating gastroesophageal reflux disease, Amneal said Monday.

January 28, 2013

The Food and Drug Administration has approved a new use for a pneumococcal vaccine made by Pfizer, the drug maker said.

January 28, 2013

The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said.

January 25, 2013

If the flu were a storm cloud, the influenza virus is hovering over America's Bread Basket on its way to the Southwest, according to data provided through the U.S. Outpatient Influenza-like Illness Surveillance Network.

January 25, 2013

The Food and Drug Administration has approved a Novartis drug for treating leukemia in children.

January 25, 2013

"Too sick to go to work, but not sick enough not to tweet about it" Twitter users are helping to predict flu trends.

January 25, 2013

The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.

January 24, 2013

A division of drug maker Teva is partnering with an advocacy group focused on asthma in the launch of a new educational website about the condition.

January 24, 2013

Perrigo and a subsidiary of K-V Pharmaceutical Co. have launched a new drug for yeast infections in women, the two companies said.

January 23, 2013

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Tuesday joined forces to honor the Bucks County, Pa.-based Bucks Promise for Youth and Communities with this year’s Dose of Prevention award.

January 23, 2013

The Food and Drug Administration has approved a new drug for removing excess iron from the blood in patients with a rare genetic disorder, the agency said.

January 23, 2013

Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

January 23, 2013

A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

January 23, 2013

Five pharmacies dominated prescription drug dispensing revenues in the United States last year, according to a new study.

January 22, 2013

The Food and Drug Administration on Friday approved the distribution of 2 million additional doses of Tamiflu (oseltamivir phosphate) 75 mg that contain an older version of the package insert.

January 22, 2013

H. D. Smith announced the establishment of H. D. Smith Specialty Solutions, an organization structured to provide focus and alignment around specialty and traditional brand products, solutions and services.

January 22, 2013

During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

January 21, 2013

Eye care company Alcon has launched a treatment for pain and inflammation resulting from cataract surgery, the company said Monday.

January 21, 2013

Drug maker GlaxoSmithKline is seeking Food and Drug Administration approval for a new treatment for Type 2 diabetes, the drug maker said.